Director · SUPERNUS PHARMACEUTICALS, INC. · Common Stock
Side
SELL
Value
$167K
Shares
3,258
Price
$51.27
Executed
Feb 19, 2026
Disclosed
Feb 23, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Feb 19 executedFeb 23, 2026 disclosed
SUPN · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Sensenig Bethany filed this Form 4 reporting a open-market sale of SUPN on Feb 19, 2026. It became public on Feb 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Sensenig Bethanycik:0001899935
Issuer
SUPERNUS PHARMACEUTICALS, INC.cik:0001356576
Revision history · 0
No field has changed since this record was first ingested.
